Study of TROP2 CAR–engineered IL‐15–transduced cord blood–derived NK cells delivered intraperitoneally for the management of platinum resistant ovarian cancer, mesonephric‐like adenocarcinoma, and pancreatic cancer. Here, TACSTD2 is linked to ovarian carcinoma.